HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REACH Registrants Should Bone Up On Alternative Test Requirements – ECHA

This article was originally published in The Rose Sheet

Executive Summary

The European Chemicals Agency examined 164 animal testing proposals last year under the EU’s REACH regulation, resulting in 133 draft decisions seeking additional information, according to its 2016 Progress Report, which includes recommendations for existing and prospective registrants. The agency has implemented a tightened approach to ensure that animal testing is undertaken only as a “last resort.”

Advertisement

Related Content

Cruelty Free International Seeks ‘More Humane’ REACH With Phase-In Registrations Now Wrapped
ECHA: Non-Animal Tests For Complex Toxicity Endpoints Not 'Foreseeable'
Never Mind IUCLID: Study Identifies Costs As Biggest Obstacle To SMEs’ REACH Registration
Industry, NGOs Still Divided On Alternative Testing With EU Ingredient Innovation Stalled
ECHA Shirking Animal-Test Avoidance Duties? Challenge May Go To EU Court
ECHA Report: 91% Of Evaluated Chemical Dossiers Came Up Short In 2016
EU Regulatory News In Brief: Non-Animal Test Guidance; REACH Enforcement Initiatives; More
ECHA Targets Cosmetic Preservatives For Review With Draft CoRAP Update
Landmark EU Ruling: Animal-Tested Cosmetic Ingredients Not Banned Per Se
ECHA May Be Stickler In 2018 For ‘Last Resort’ Animal Tests Only

Topics

Advertisement
UsernamePublicRestriction

Register

RS109110

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel